About
Lembas develops natural, clinically validated bioactive ingredients for functional foods and supplements, using an AI-powered discovery platform. Its lead product, GLP-1 Edge™, is a food-grade peptide that enhances the body’s GLP-1 response to support appetite regulation and metabolic health. Designed for seamless integration into formats like bars, shakes, and supplements, it enables natural weight management without pharmaceutical intervention.
The company’s proprietary AI platform accelerates the design of targeted peptides, leveraging patent-pending academic technology to expand into additional health applications. Lembas combines computational biology with food science to bring precision bioactives into everyday nutrition.
Funding history · 1 round · $3.6M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- When was Lembas founded?
- Lembas was founded in May 2024.
- What is Lembas's primary product?
- Lembas's primary product is GLP-1 Edge™, a food-grade peptide designed to enhance the body’s GLP-1 response for appetite regulation and metabolic health, supporting natural weight management.
- What technology does Lembas use for product discovery?
- Lembas utilizes a proprietary AI-powered discovery platform to accelerate the design of targeted peptides.
- How much funding has Lembas raised in total?
- Lembas has raised a total of $3.6 million USD.
- When did Lembas complete its Pre-Seed funding round and who were the lead investors?
- In June 2025, Lembas completed a $3.6 million Pre-Seed funding round, with FLORA Ventures as a lead investor.
- Where is Lembas headquartered?
- Lembas is headquartered in Tel Mond, Israel.
- Does Lembas have any other offices?
- Yes, Lembas has an office in Sheffield, United Kingdom.
- How many employees does Lembas currently have?
- Lembas currently has 1-10 employees.
- When did Lembas emerge from stealth mode?
- Lembas emerged from stealth mode in June 2025, announcing its breakthrough discovery in natural GLP-1 for weight management.